(Q35159258)

6 August 2017

title

Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial (English)

1 reference

Charcot-Marie-Tooth disease type 1A

6 August 2017

main subject

1 reference

Lucio Santoro

6

0 references

Giuseppe Vita

object named as

Giuseppe Vita

7

0 references

Francesco Visioli

object named as

Francesco Visioli

11

0 references

Aldo Quattrone

8

object named as

Aldo Quattrone

1 reference

6 August 2017

2

Mary M Reilly

1 reference

6 August 2017

Davide Pareyson

1

1 reference

6 August 2017

Angelo Schenone

3

1 reference

6 August 2017

Gian Maria Fabrizi

4

1 reference

6 August 2017

Tiziana Cavallaro

5

1 reference

6 August 2017

Luca Padua

9

1 reference

6 August 2017

Franco Gemignani

10

1 reference

6 August 2017

Matilde Laurà

12

1 reference

6 August 2017

Davide Radice

13

1 reference

6 August 2017

Daniela Calabrese

14

1 reference

6 August 2017

Richard A C Hughes

15

1 reference

6 August 2017

Alessandra Solari

16

1 reference

6 August 2017

CMT-TRIAAL

17

1 reference

6 August 2017

CMT-TRAUK groups

18

1 reference

6 August 2017

publication date

1 April 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

320-328

1 reference

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Ascorbic acid inhibits PMP22 expression by reducing cAMP levels.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

The methanol method for the quantification of ascorbic acid and dehydroascorbic acid in biological samples

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

The MOS 36-ltem Short-Form Health Survey (SF-36)

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Ascorbic acid for treatment of CMT1A: the jury is still out.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Reliability and validity of the CMT neuropathy score as a measure of disability.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

The Italian SF-36 Health Survey: translation, validation and norming

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154498

136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands

27 September 2018

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

1 reference

12 December 2020

Neuropathy progression in Charcot-Marie-Tooth disease type 1A

1 reference

12 December 2020

168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT)

1 reference

12 December 2020

10.1016/S1474-4422(11)70025-4

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference